0000932440-17-000049.txt : 20170720 0000932440-17-000049.hdr.sgml : 20170720 20170720160827 ACCESSION NUMBER: 0000932440-17-000049 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170509 FILED AS OF DATE: 20170720 DATE AS OF CHANGE: 20170720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHREIBER ALAIN CENTRAL INDEX KEY: 0001225149 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 17974446 MAIL ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ProQuest Associates IV LLC CENTRAL INDEX KEY: 0001431819 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 17974448 BUSINESS ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 BUSINESS PHONE: 609-919-3567 MAIL ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ProQuest Investments IV, L.P. CENTRAL INDEX KEY: 0001431818 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 17974449 BUSINESS ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 BUSINESS PHONE: 609-919-3567 MAIL ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moorin Jay CENTRAL INDEX KEY: 0001033508 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 17974447 MAIL ADDRESS: STREET 1: C/O PROQUEST INVESTMENTS, L.P STREET 2: 2430 VANDERBILT BEACH ROAD, #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 FORMER NAME: FORMER CONFORMED NAME: MOORIN JAY DATE OF NAME CHANGE: 19970213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2017-05-09 0 0001668243 UroGen Pharma Ltd. URGN 0001431818 ProQuest Investments IV, L.P. 2430 VANDERBILT BEACH ROAD, #108 - 190 NAPLES FL 34109 0 0 1 0 0001431819 ProQuest Associates IV LLC 2430 VANDERBILT BEACH ROAD, #108 - 190 NAPLES FL 34109 0 0 1 0 0001033508 Moorin Jay C/O PROQUEST INVESTMENTS 2430 VANDERBILT BEACH ROAD, #108 - 190 NAPLES FL 34109 0 0 1 0 0001225149 SCHREIBER ALAIN C/O PROQUEST INVESTMENTS 2430 VANDERBILT BEACH ROAD, #108 - 190 NAPLES FL 34109 0 0 1 0 Ordinary Shares, par value NIS 0.01 per share 1451329 D The securities are directly held by ProQuest Investments IV, L.P. and indirectly held by ProQuest Associates IV, LLC, the General Partner of ProQuest Investments IV, L.P. The individual managing members of ProQuest Associates IV, LLC are Jay Moorin and Alain Schreiber, M.D., who may be deemed to have shared voting and investment and dispositive power with respect to these shares. Each individual managing member disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares. /s/ Pasquale DeAngelis 2017-07-20 EX-24 2 poa.htm POWER OF ATTORNEY

                                                                                       Exhibit 24.1



                                         POWER OF ATTORNEY



KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned hereby constitutes

and appoints, as of the date hereof, Pasquale DeAngelis, his or her true and lawful attorney-in-fact

with full power of substitution, resubstitution and revocation, for the undersigned and in the

undersigned's name, place and stead, in any and all capacities, including, but not limited to, the

undersigned's individual capacity, to execute all agreements, certificates, forms, instruments, or

other documents, and to take any action, necessary to file beneficial ownership reports on

Schedules 13D and 13G and Forms 3, 4 and 5 (including any amendments thereto, and including

any beneficial ownership reports which may in the future be required by the Securities and

Exchange Commission to be filed provided that the purpose and form of such reports is

substantially similar to Schedules 13D or 13G or Form 3, 4 or 5) under the Securities Exchange

Act of 1934 with the Securities and Exchange Commission or any stock exchange or similar

authority, in connection with any equity investments in Urogen Pharma Ltd. by each of the

undersigned in his or her individual capacity.



In connection with the appointment of such attorney-in-fact, each of the undersigned hereby

grants unto said attorney-in-fact full power and authority to do and perform each and every act

and thing which, in the opinion of such attorney-in-fact, may be requisite, necessary, proper or of

benefit to be done in and about the premises, as fully to all intents and purposes as the

undersigned might or could do in person, thereby ratifying and confirming all that said

attorney-in-fact (or attorney-in-fact's substitute or substitutes), may lawfully do or cause to be

done by virtue hereof, it being understood that the documents executed by such attorney-in-fact on

behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain

such terms and conditions as such attorney-in-fact may approve in his own discretion. Each of the

undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the

request of the undersigned, is not assuming any of the undersigneds' responsibilities to comply with

Section 13 or Section 16 of the Securities Exchange Act of 1934.



This Power of Attorney shall remain in full force and effect until each of the undersigned is no

longer required to file Forms 3, 4 and 5 or Schedules 13D or 13G with respect to the undersigned's

holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the

undersigned in a signed writing delivered to the foregoing attorney-in-fact.







Dated:  July 20, 2017

                                                  /s/ Jay Moorin

                                                  ______________________________

                                                  Jay Moorin









                                                  /s/ Alain Schreiber

                                                  ______________________________

                                                  Alain Schreiber